Safety of Nonsteroidal Antiinflammatory Drugs in Patients with Cardiovascular Disease

被引:30
作者
Danelich, Ilya M. [1 ]
Wright, Sampaguita S. [1 ]
Lose, Jennifer M. [1 ]
Tefft, Brittany J. [1 ]
Cicci, Jonathan D. [2 ]
Reed, Brent N. [3 ]
机构
[1] Mayo Clin, Dept Pharm, Rochester, MN USA
[2] Univ North Carolina Hosp, Dept Pharm, Chapel Hill, NC USA
[3] Univ Maryland, Sch Pharm, Dept Pharm Practice & Sci, Baltimore, MD 21201 USA
来源
PHARMACOTHERAPY | 2015年 / 35卷 / 05期
关键词
nonsteroidal antiinflammatory drugs; cardiovascular disease; cardiac surgery; noncardiac surgery; bleeding; CONGESTIVE-HEART-FAILURE; MYOCARDIAL-INFARCTION; ELDERLY-PATIENTS; BLOOD-PRESSURE; CYCLOOXYGENASE-2; INHIBITORS; COX-2; INCREASED RISK; NSAIDS; OSTEOARTHRITIS; CELECOXIB;
D O I
10.1002/phar.1584
中图分类号
R9 [药学];
学科分类号
100702 [药剂学];
摘要
Nonsteroidal antiinflammatory drugs (NSAIDs) are used in the management of a variety of conditions, but their prevalence is likely underreported as a result of widespread availability and the perception that nonprescription therapies are unnecessary to report during medication history taking. However, NSAIDs are associated with a number of adverse effects, especially in patients with cardiovascular disease (CVD). Patients with CVD and comorbidities for which NSAIDs may provide symptomatic relief (e.g., osteoarthritis, rheumatoid arthritis) tend to be older, which places them at greater risk of harm. For these reasons, the use of NSAIDs in patients with CVD is a significant public health concern. An understanding of the risks associated with NSAIDs is critical for clinicians across practice settings. In this review, we detail the safety of NSAIDs in patients with CVD, provide recommendations on their use in specific disease states, and discuss therapeutic alternatives.
引用
收藏
页码:520 / 535
页数:16
相关论文
共 59 条
[1]
Practice Guidelines for Acute Pain Management in the Perioperative Setting An Updated Report by the American Society of Anesthesiologists Task Force on Acute Pain Management [J].
Ashburn, Michael A. ;
Caplan, Robert A. ;
Carr, Daniel B. ;
Connis, Richard T. ;
Ginsberg, Brian ;
Green, Carmen R. ;
Lema, Mark J. ;
Nickinovich, David G. ;
Rice, Linda Jo .
ANESTHESIOLOGY, 2012, 116 (02) :248-273
[2]
Impact of non-steroidal anti-inflammatory drugs (NSAIDs) on cardiovascular outcomes in patients with stable atherothrombosis or multiple risk factors [J].
Barthelemy, Olivier ;
Limbourg, Tobias ;
Collet, Jean Philippe ;
Beygui, Farzin ;
Silvain, Johanne ;
Bellemain-Appaix, Anne ;
Cayla, Guillaume ;
Chastre, Thomas ;
Baumgartner, Iris ;
Roether, Joachim ;
Zeymer, Uwe ;
Bhatt, Deepak L. ;
Steg, Gabriel ;
Montalescot, Gilles .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 163 (03) :266-271
[3]
Rationale, design, and governance of Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofen Or Naproxen (PRECISION), a cardiovascular end point trial of nonsteroidal antiinflammatory agents in patients with arthritis [J].
Becker, Matthew C. ;
Wang, Thomas H. ;
Wisniewski, Lisa ;
Wolski, Kathy ;
Libby, Peter ;
Luescher, Thomas F. ;
Borer, Jeffrey S. ;
Mascette, Alice M. ;
Husni, M. Elaine ;
Solomon, Daniel H. ;
Graham, David Y. ;
Yeomans, Neville D. ;
Krum, Henry ;
Ruschitzka, Frank ;
Lincoff, A. Michael ;
Nissen, Steven E. .
AMERICAN HEART JOURNAL, 2009, 157 (04) :606-612
[4]
Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials [J].
Bhala, N. ;
Emberson, J. ;
Merhi, A. ;
Abramson, S. ;
Arber, N. ;
Baron, J. A. ;
Bombardier, C. ;
Cannon, C. ;
Farkouh, M. E. ;
FitzGerald, G. A. ;
Goss, P. ;
Halls, H. ;
Hawk, E. ;
Hawkey, C. ;
Hennekens, C. ;
Hochberg, M. ;
Holland, L. E. ;
Kearney, P. M. ;
Laine, L. ;
Lanas, A. ;
Lance, P. ;
Laupacis, A. ;
Oates, J. ;
Patrono, C. ;
Schnitzer, T. J. ;
Solomon, S. ;
Tugwell, P. ;
Wilson, K. ;
Wittes, J. ;
Baigent, C. ;
Adelowo, O. ;
Aisen, P. ;
Al-Quorain, A. ;
Altman, R. ;
Bakris, G. ;
Baumgartner, H. ;
Bresee, C. ;
Carducci, M. ;
Chang, D-M. ;
Chou, C-T. ;
Clegg, D. ;
Cudkowicz, M. ;
Doody, L. ;
El Miedany, Y. ;
Falandry, C. ;
Farley, J. ;
Ford, L. ;
GarciLosa, M. ;
Gonzalez-Ortiz, M. ;
Haghighi, M. .
LANCET, 2013, 382 (9894) :769-779
[5]
Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison [J].
Cannon, Christopher P. ;
Curtis, Sean P. ;
FitzGerald, Garret A. ;
Krum, Henry ;
Kaur, Amarjot ;
Bolognese, James A. ;
Reicin, Alise S. ;
Bombardier, Claire ;
Weinblatt, Michael E. ;
van der Heijde, Desiree ;
Erdmann, Erland ;
Laine, Loren .
LANCET, 2006, 368 (9549) :1771-1781
[6]
COX-2 Inhibitors and Cardiovascular Risk [J].
Cannon, Christopher P. ;
Cannon, Paul J. .
SCIENCE, 2012, 336 (6087) :1386-1387
[7]
Pharmacodynamic interaction of naproxen with low-dose aspirin in healthy subjects [J].
Capone, ML ;
Sciulli, MG ;
Tacconelli, S ;
Grana, M ;
Ricciotti, E ;
Renda, G ;
Di Gregorio, P ;
Merciaro, G ;
Patrignani, P .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (08) :1295-1301
[8]
Cyclooxygenase inhibitors and the antiplatelet effects of aspirin. [J].
Catella-Lawson, F ;
Reilly, MP ;
Kapoor, SC ;
Cucchiara, AJ ;
DeMarco, S ;
Tournier, B ;
Vyas, SN ;
FitzGerald, GA .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (25) :1809-1817
[9]
Stroke risk and NSAIDs: an Australian population-based study [J].
Caughey, Gillian E. ;
Roughead, Elizabeth E. ;
Pratt, Nicole ;
Killer, Graeme ;
Gilbert, Andrew L. .
MEDICAL JOURNAL OF AUSTRALIA, 2011, 195 (09) :525-529
[10]
The association between the use of non-steroidal anti-inflammatory drugs and atrial fibrillation: A nationwide case-control study [J].
Chao, Tze-Fan ;
Liu, Chia-Jen ;
Chen, Su-Jung ;
Wang, Kang-Ling ;
Lin, Yenn-Jiang ;
Chang, Shih-Lin ;
Lo, Li-Wei ;
Hu, Yu-Feng ;
Tuan, Ta-Chuan ;
Wu, Tsu-Juey ;
Chen, Tzeng-Ji ;
Tsao, Hsuan-Ming ;
Chen, Shih-Ann .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 168 (01) :312-316